Alexion Pharmaceuticals, Inc. Overview
Company Headquarters: Boston, US
Founded: 1992
Workforce: ~ 3082
Company Working: Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company. The company researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. It develops C5 complement inhibitors and apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system. The company has 4 growing, durable franchises and it serves more than 50 countries including major regions such as North America, Latin America, Europe, the Middle East, and Asia-Pacific.
Strategy
Alexion Pharmaceuticals, Inc. emphasizes serving patients and families affected by rare diseases through the discovery, development, and commercialization of life-changing therapies. The company focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders, and cardiology.
